News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Dr. Girish Chinnaswamy has been elected Vice-Chair of the SIOP PARC Programme
Photo from SIOP/LinkedIn
Jul 5, 2024, 02:36

Dr. Girish Chinnaswamy has been elected Vice-Chair of the SIOP PARC Programme

International Society of Paediatric Oncology – SIOP shared on LinkedIn:

“Congratulations to Dr. Girish Chinnaswamy (India) on being elected Vice-Chair of the SIOP PARC Programme!

More about the SIOP PARC Programme here.”

Source: SIOP/LinkedIn

SIOP (International Society of Paediatric Oncology) is the only global multidisciplinary society entirely devoted to pediatric and adolescent cancer. The society has over 2,600 members worldwide including doctors, nurses, other healthcare professionals, scientists, and researchers. SIOP’s vision is that no child should die of cancer: cure for more, care for all.

.

cancer Girish Chinnaswamy International Society of Paediatric Oncology OncoDaily Oncology SIOP SIOP PARC Programme Vice-Chair
Special Coverage
Science
Jan 14, 2025, 19:05
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Societies
Jan 14, 2025, 19:03
Become a CancerX 2025 Accelerator Mentor
Blog
Jan 14, 2025, 18:58
Professor Tak Mak shares the story behind his discovery of the T Cell Receptor - SPCC
Science
Jan 14, 2025, 18:51
Abi Siva: Another step close to De-escalation
Science
Jan 14, 2025, 18:49
Naveen Pemmaraju: Addition of navitoclax to ruxolitinib for patients with myelofibrosis
Blog
Jan 14, 2025, 18:47
Zeena Salman: Five-year anniversary working with St. Jude Children's Research Hospital
Dialogues
Jan 14, 2025, 18:45
United by Unique: Centering Care Around People and Their Stories
Blog
Jan 14, 2025, 18:40
Anna Rathkopf: Learning about Breast Density after a cancer diagnosis
Blog
Jan 14, 2025, 18:40
GSK has announced agreement to acquire the U.S. biotech firm IDRx for up to $1.15 billion
Blog
Jan 14, 2025, 18:30
Keynote Lecture by Pamela Kunz to Highlight Need for Inclusive Science in GI Cancers - ASCO
Blog
Jan 14, 2025, 18:21
Applications are open for the LUNGevity Research Awards
Insight
Jan 14, 2025, 18:15
James Crowley: ctDNA Origins, Cancer Biology and Clinical Study Needs